tradingkey.logo
tradingkey.logo

Imunon Announces First Patient Dosed In Phase 3 Ovation 3 Study Of Imnn-001 In Newly Diagnosed Advanced Ovarian Cancer

ReutersJul 30, 2025 1:01 PM

- Imunon Inc IMNN.O:

  • IMUNON ANNOUNCES FIRST PATIENT DOSED IN PHASE 3 OVATION 3 STUDY OF IMNN-001 IN NEWLY DIAGNOSED ADVANCED OVARIAN CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI